Therapeutic Antibodi - Directors Shareholding

RNS No 9634h
THERAPEUTIC ANTIBODIES INC
11th December 1998


Schedule 11 - Notification of interests of Directors and Connected Persons

1   Name of company:
THERAPEUTIC ANTIBODIES INC

2   Name of director:
MARTIN S. BROWN

3   Please state whether notification indicates that it is in respect of     
holding of the director named in 2 above or holding of that person's spouse or
children under the age of 18 or in respect of a non- beneficial interest:
DIRECTOR NAMED IN 2 ABOVE

4   Name of registered holder(s) and, if more than one holder, the number of 
shares held by each of them (if notified):
MARTIN S BROWN

5   Please state whether notification relates to a person(s) connected with  
the director named in 2 above and identify the connected person(s):
N/A

6   Please state the nature of the transaction. For PEP transactions please  
indicate whether general/single co PEP and if discretionary/non discretionary:
RECEIPTS OF OPTIONS

7   Number of shares/amount of stock acquired:
N/A

8   Percentage of issued class:
N/A

9   Number of shares/amount of stock disposed:
N/A

10  Percentage of issued class:
N/A

11  Class of security:
OPTIONS TO SUBSCRIBE FOR COMMON STOCK  OF US $0.001 PER SHARE

12  Price per share:
N/A

13  Date of transaction:
11 DECEMBER 1998

14  Date company informed:
11 DECEMBER 1998

15  Total holding following this notification:
1)OPTIONS AND WARRANTS FOR 284,000 SHARES 2) 3,761,224 BENEFICIALLY OWNED
SHARES

16  Total percentage holding of issued class following this notification:
1)   0.55%         2)  7.23%

If a director has been granted options by the company, please complete the
following fields:

17  Date of grant:
11 DECEMBER, 1998

18  Period during which or date on which exercisable:
31 DECEMBER, 1998 - 21 DECEMBER, 2008

19  Total amount paid (if any) for grant of the option:
N/A

20  Description of shares or debentures involved: class, number:
5,000 SHARES OF COMMON STOCK OF US$ 0.001 PER SHARE

21  Exercise price (if fixed at time of grant) or indication that price is to
be fixed at time of exercise:
$0.90

22  Total number of shares or debentures over which options held following
this notification:
205,000

23  Contact name for queries:
SAUL KOMISAR

24  Contact telephone number:
0171 638 4010 

25  Name of company official responsible for making notification:
PHIL WALKER

Additional Information:

END


RDSFCDCKPDDDCBD